FAST, NCT02611973: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia |
|
|
| Recruiting | 3 | 2250 | Europe | Aspirin therapy interruption, Usual treatment by aspirin 100 mg/d in the active comparator arm, No interruption of aspirin in the Observational arm, Hydroxyurea treatment (HU) | Assistance Publique - Hôpitaux de Paris | MPN, Essential Thrombocythemia | 11/19 | 11/22 | | |
NCT01930253: Use of Bortezomib to Treat Refractory Autoimmune Cytopenia(s) in Allogeneic Stem Cell Transplantation |
|
|
| | 1 | 5 | US | Bortezomib, Velcade | Children's Hospital Medical Center, Cincinnati | Refractory Autoimmune Cytopenia(s) | 01/14 | 01/14 | | |